North Bethesda, MD, United States of America

David M Simpson

This inventor holds 16 USPTO granted patents and 6 published patent applications and 4 EPO patents. Top assignees: Pharma Cinq, LLC, Igen International, Inc., Igen, Inc.. Active years: 1997-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David M Simpson. Retrieved from https://idiyas.com/inventor/david-m-simpson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 6)

% Patents Active = 100.0

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 137(Granted Patents)

Location History:

Adelphi, MD (US) (1997 - 2001)
N. Bethesda, MD (US) (2001)
Adelphia, MD (US) (2001 - 2004)
North Bethesda, MD (US) (2018 - 2021)

Company Filing History:

Igen International, Inc.

Wellstat Therapeutics Corporation

Years Active: 1997-2026

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12703718 - Compositions and compounds for co-delivery of uridine and ketoleucine (2026-08-11),

2. 12649739 - Imidazoquinoline compound having anti-inflammatory, antifugal, antiparasitic, and anticancer activity (2026-06-09),

3. 12630580 - 5'-O-phenylacetyluridine and therapeutic use (2026-05-19),

4. 12577270 - 2',3′-diacetyluridine substituted with acetoacetyl at the 5′ position (2026-03-17),

5. 12139483 - Imidazoquinolyl compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity (2024-11-12),

6. 10934284 - Aminoquinazoline compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity (2021-03-02),

7. 10030015 - Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity (2018-07-24),

8. 6702705 - Prodrugs activated by targeted catalytic proteins (2004-03-09),

9. 6258360 - Prodrugs activated by targeted catalytic proteins (2001-07-10),

10. 6218519 - Compounds and methods for the selective treatment of cancer and bacterial infections (2001-04-17),

11. 6177270 - Reaction-based selection for expression of and concentration of catalytic moieties (2001-01-23),

12. 6121007 - Reaction-based selection for expression of and concentration of (2000-09-19),

13. 5891648 - Reaction-based selection for expression of and concentration of (1999-04-06),

14. 5631137 - Reaction-based selection for expression of and concentration of (1997-05-20),

15. 5597573 - Lipid-A analogs: new monosaccharide and disaccharide intermediates for (1997-01-28),

Title: The Innovative Journey of David M Simpson

Introduction: David M Simpson, a talented inventor based in North Bethesda, MD (US), has made significant contributions to the field of technology through his creative and groundbreaking inventions.

Latest Patents: David M Simpson holds several patents in various technological areas, including artificial intelligence, renewable energy, and medical devices. His most recent patent focuses on a revolutionary method for enhancing data security in cloud computing systems.

Career Highlights: With a background in computer science and engineering, David M Simpson has a successful career marked by a series of innovative projects. He has worked for leading tech companies, where he played a key role in developing cutting-edge technologies that have shaped the industry.

Collaborations: Throughout his career, David M Simpson has collaborated with top researchers, engineers, and scientists to bring his ideas to life. His collaborative spirit and passion for innovation have led to the successful implementation of several groundbreaking projects.

Conclusion: David M Simpson's dedication to innovation and his relentless pursuit of technological advancement have established him as a prominent figure in the world of inventors. His work continues to inspire and drive progress in the ever-evolving field of technology.

Profile summary based on public USPTO records.